Loading clinical trials...
Loading clinical trials...
This study is a randomised control trial comparing Castomize 4D printed cast versus conventional fibreglass casts in isolated conservatively treated distal radius fractures. The primary outcome measure is fracture reduction. Secondary outcome measures include patient reported outcome measures such as the Adult Rated Cast Evaluation Questionnaire (ARCEQ), comfort of the cast, quality of life assessed with the EQ-5D-5L questionnaire, cost-effectiveness and adverse events occurrence. In total, 30 patients will be included and followed for 6 months.
Age
21 - No limit years
Sex
ALL
Healthy Volunteers
No
Tan Tock Seng Hospital
Singapore, Singapore
Start Date
January 14, 2024
Primary Completion Date
June 1, 2025
Completion Date
December 25, 2025
Last Updated
January 20, 2026
25
ACTUAL participants
Castomize cast
DEVICE
Control
OTHER
Lead Sponsor
Tan Tock Seng Hospital
NCT05650996
NCT06678438
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06913920